Prohibitin-targeting peptide 1, the active substance in Adipotide (FTPP) 5 mg, is a synthetic peptide designed to target prohibitin on adipose tissue vasculature, inducing fat cell apoptosis. It is used in research to study fat loss and metabolic effects, with no aromatization and low hepatic toxicity.
Common side effects of Adipotide (FTPP) 5 mg include dehydration, kidney strain (elevated creatinine), fatigue, and injection site irritation. Less common issues include nausea or electrolyte imbalance. Manage with hydration, kidney function monitoring (e.g., Milk Thistle), and PCT; consult a professional if severe.
Adipotide (FTPP) 5 mg should be injected daily due to its short half-life, with a typical dosage of 250-500 mcg (0.25-0.5 ml) per injection. Use sterile syringes (29-31 gauge, 0.5-1 inch needle), and adjust based on bloodwork and professional guidance. Cycle length is usually 4-6 weeks.
Adipotide (FTPP) 5 mg has a short half-life of approximately 1-2 hours, requiring daily injections. It remains detectable in the body for about 24-48 hours, depending on dosage, metabolism, and testing methods. Bloodwork and professional guidance are advised for precise clearance timelines.
Prohibitin-targeting peptide 1 binds to prohibitin on fat cell vasculature, inducing apoptosis (programmed cell death) in adipose tissue without affecting healthy cells. Users notice fat loss within 1-2 weeks. What doesn't happen: no significant water retention or liver toxicity, but kidney control is critical.
Adipotide (FTPP) 5 mg excels for bodybuilders in cutting cycles, requiring a high-protein diet and intense training to maximize its fat-loss potential.
Best for experienced bodybuilders seeking fat loss or cutting results; suitable for men. Not recommended for beginners, women (due to virilization risk), or those with kidney issues.
| Substance | Prohibitin-targeting peptide 1 |
|---|---|
| Concentration | 5 mg |
| Form | Injectable vial |
| Pack Size | vial |
| Half-life | ~1-2 hours |
| Aromatization/Hepatic | Non-aromatizing / Low hepatic |
| Primary Use | Fat loss, metabolic health |
| Manufacturer | Generic Peptides |
| Brand | Adipotide |
Clenbuterol: Enhances fat loss.
T3 Tablets: Amplifies metabolism.
Yohimbine: Boosts fat burning.
Cycle Support: Supports kidney health during cycles.
Adipotide (FTPP) 5 mg vs Clenbutaxyl: Adipotide targets fat cells; Clenbutaxyl is a stimulant.
Adipotide (FTPP) 5 mg vs Thyroxyl (T3): Adipotide induces apoptosis; T3 boosts metabolism.
Adipotide (FTPP) 5 mg vs HGH Fragment: Both target fat; HGH Fragment is hGH-derived.
Consult a professional to ensure safe use and monitor renal, cardiovascular, and kidney health.
Start PCT 3-4 days after last injection due to short half-life; use tamoxifen (20-40 mg/day) or clomiphene (50-100 mg/day) for 4 weeks, possibly with HCG (500-1000 IU/week) for severe suppression. Bloodwork guides HPTA recovery, ensuring sustained gains and hormonal balance.
What are the benefits of taking Adipotide?
Benefits include fat loss and metabolic health; see What Are the Benefits of Taking Adipotide. Manage with care—consult professionals.
How long does it take for adipotides to work?
It takes 1-2 weeks for effects; see How Long Does It Take for Adipotides to Work. Monitor progress—consult professionals.
How to take Adipotide?
Take 250-500 mcg daily; see How to Take Adipotide. Use sterile technique—consult professionals.
Are Adipotide (FTPP) 5mg safe?
It can be safe with oversight, but risks exist; see Are Adipotide (FTPP) 5mg Safe. Consult professionals for monitoring.